16th Annual Conference of The Oncofertility Consortium

Monday, November 11, 2024, 8:00 AM - Wednesday, November 13, 2024, 12:00 PM, Detroit Marriott Renaissance Center, Detroit, MI


AMA PRA Category 1 Credits™ (19.00 hours), ABIM MOC Part 2 (19.00 hours), ABS CC (19.00 hours), AMA PRA Non-Physician Attendance (19.00 hours)

The 16th Annual Conference of the Oncofertility Consortium, November 11-13, 2024, hosted by Henry Ford Health & Michigan State University Health Sciences at Detroit Marriott Renaissance Center, MI, USA, with the theme of “Unveiling Insights: Harnessing Our Data, Shaping Tomorrow's Impact”. The Annual Conference of the Oncofertility Consortium provides an accessible platform for national and international oncofertility leaders and those new to the field to share their perspectives, discoveries, and vision for the field of fertility preservation from basic science to translational research to clinical application. The conference offers unique opportunities for attendees to network and convene in-person and participate in this cutting-edge field and develop new initiatives for the upcoming years. All interested physicians, researchers, scientists, scholars, students, nurses, allied health professionals, social workers and patient advocates are welcome!

1. Understand the most recent clinical and research updates in the field of Oncofertility.
2. Participate in an advocacy effort if they desire
3. Appreciate how big data can improve clinical care in Oncofertility.

**If you register after 11/8 at 3pm, please email [email protected] to request the 'Welcome Attendees' email so you get all the event details.**

 

*Conference registration provides access to all sessions of the conference including Oncofertility 101 Course.

*Oncofertility 101 Course registration does not provide access to other sessions of the conference.

 

Day 1 (as an alternative to the Oncofertility 101 course) there is also a Non-CME: Pre-Event Scientific Committees Breakout Sessions from 8am - 12pm - the Hosting Dept to provide details via email after registration

 

CME Credits available:

* All 3 days (with the Oncofertility 101 course on day 1) = 19.0

* All 3 days (but not with the Oncofertility 101 course on day 1) = 15.25

* Day 1 (with the Oncofertility 101 course on day 1) = 7.75

* Day 1 (Oncofertility 101 course only) = 3.75

* Day 2 = 7.50

* Day 3 = 3.75

            

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Henry Ford Health and the Oncofertility Consortium. Henry Ford Health is accredited by the ACCME to provide continuing medical education for physicians. 

DESIGNATION STATEMENT:

Henry Ford Health designates this live course for a maximum of 19.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

 

MOC STATEMENT:

“Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn:
- up to 19.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
- 19.0 credit toward the CME requirement(s) of the American Board of Surgery’s (ABS) Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit. There is a 30-day post-event evaluation completion deadline to receive your CME/MOC credits.”

After completing the evaluation click the Claim MOC button to finalize the submission & then ensure your CloudCME profile reflects the following required details so we can correctly transmit your credits:

• Click Yes to Claiming MOC & enter your Birth Month & Birth Day
• Then select the MOC Board & Enter your Diplomate ID (for ABIM) or Learner ID (for ABS)
• You must have the option selected at the bottom of your profile to provide permission for us to share & transmit your CME/MOC data to ACCME

 

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT: 

 In compliance with the ACCME standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose all financial interests of their own with any ACCME defined commercial interests for the past 24 months and/or non-FDA approved use of a drug or a device that is included in the presentation. All financial relationships have been mitigated prior to the commencement of the activity.

 

ACCESSIBILITY STATEMENT: 

Henry Ford Health provides qualified interpreters and other aids for Deaf, DeafBlind, and Hard-of-Hearing persons at no cost. To request assistance, contact the event coordinator: Tina Miller at [email protected]. Please allow a minimum of 3 days to process this request.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

The registration form for this activity is currently unavailable.

Detroit Marriott Renaissance Center

400 Renaissance Dr

Detroit, MI 48243

Detroit Marriott at the Renaissance Center

Ph: 313-568-8000

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.